Novel Psilocin Derivatives as Serotonergic Psychedelic Agents for Treating CNS Disorders
ACS Medicinal Chemistry Letters October 22, 2025 DOI: 10.1021/acsmedchemlett.5c00608 (opens in new tab) via OpenAlex
Summary
AI-generated from the abstractThis work describes novel psilocin derivatives designed as serotonergic psychedelic agents. It covers pharmaceutical compositions containing these compounds, their use in treating central nervous system disorders, and processes for preparing them.
Study at a glance
| Characteristics | Peer reviewed |
|---|---|
| Topics | Serotonin |
| Keywords | Central nervous system Hallucinogen Neuropharmacology |
Abstract
High Resolution Image Download MS PowerPoint Slide Provided herein are novel psilocin derivatives as serotonergic psychedelic agents, pharmaceutical compositions, use of such compounds in treating central nervous system (CNS) disorders, and processes for preparing such compounds.